| Dear Voornaam, Welcome to your October newsletter. Throughout the summer weve been asking for your ideas to help shape the next round of Grand Challenge. We held our second challenge-setting workshop in Milan last month with our partners Fondazione AIRC per la Ricerca sul Cancro, and later this month well be in Edinburgh and London to discuss the biggest challenges in cancer research, from evolution and metastasis, to novel therapeutic approaches. Find out more about how you can get involved in shaping our next round of challenges below. Our early detection team is just back from a hugely successful conference in Stanford, where it was great to be part of a growing community of nearly 400 scientists and clinicians sharing their work and discussing new avenues for research in early detection. And finally, Id like to make you aware that the Cancer Research UK-MedImmune Alliance Laboratory is now known as the Cancer Research UK-AstraZeneca Antibody Alliance Laboratory. This laboratory provides access to world-class antibody engineering technology and cancer biology expertise. The change comes due to the retirement of the Medimmune brand as part of their acquisition by AstraZeneca, however the lab retains all Medimmune-associated expertise. Kind regards, Iain Foulkes Executive Director, Research & Innovation Cancer Research UK |
|
|---|
|
|---|
|
|
| | | ALL CAREER STAGES 04 November 2019 |
|
|---|
|
|---|
| | | EARLY CAREER RESEARCHER, MID-CAREER RESEARCHER, ESTABLISHED INDEPENDENT RESEARCHER, CLINICIAN, NON-CLINICAL RESEARCHER 06 December 2019 |
|
|---|
|
|---|
| | | POSTDOCTORAL RESEARCHERS, PROFESSORS, CLINICIANS, START-UPS 07 January 2020 |
|
|---|
|
|---|
| | | ALL CAREER STAGES 10 January 2020 |
|
|---|
|
|---|
|
|
 LAST CHANCE TO REGISTER FOR THE INNOVATION SUMMIT Today, 3 October, is your last chance to sign-up to our second Innovation Summit taking place on 7 October at Alderley Park. The programme will focus on how to overcome the barriers in translating research. Youll hear from researchers who have embraced entrepreneurialism and discuss their journey and what they've learnt. Join us to build your supportive entrepreneurial network, and to engage personally with Cancer Research UK, our partners and local industry through 1-on-1 advice clinics. |
|
|---|
|  LEARN ENTREPRENEURIAL SKILLS TO ACCELERATE YOUR CAREER We are pleased to announce two new partnerships with Deep Science Ventures (DSV) and Panacea to support PhD students, postdocs and junior group leaders to become entrepreneurs. Researchers can apply to either programme and, if selected, be part of an oncology-focused cohort to learn how to transform innovative ideas into viable companies that can one day benefit patients. You can find out more about the opportunities and meet DSV and Panacea at the upcoming Innovation Summit and at university roadshows. |
|
|---|
|
|---|
|
|
| | SUPPORTING YOUR RESEARCH CAREER This September, we signed the Concordat to Support the Career Development of Researchers. This agreement between funders and employers aims to improve employment conditions and support for researchers in the UK. The Concordat seeks to drive systematic change and create the healthy and supportive culture needed to ensure our researchers are given every opportunity to thrive. We are committed to realising this change through our funding requirements and polices and continuing to work with fellow signatories to support researchers well-being and development. |
|
|---|
|
|---|
|
|
 EPS IN ONCOLOGY: LAST TICKETS REMAINING With less than a month to go to the Cancer Research UKAACR Joint Conference on Engineering and Physical Sciences in Oncology, there's just enough time to book your spot. Enjoy an exciting line-up of sessions over 3 days including: - Emerging technologies for cancer diagnosis; Jason Lewis (Memorial Sloan Kettering Cancer Center)
- Cancer biophysics and clinical challenges; Owen Sansom (CRUK Beatson Institute)
- Engineered solutions to enhance therapy; Paula Hammond (Massachusetts Institute of Technology)
You'll also hear from our keynote speakers, Sylvia Plevritis (Stanford University) and Ben Simons (Cambridge University). |
|
|---|
|  HELP US SET THE NEXT ROUND OF GRAND CHALLENGES Get involved in shaping the next round of Grand Challenge: - Submit your idea online: Use your unique perspective to articulate a challenge that could change the face of cancer research.
- Run your own workshop: Gather the sharpest minds at your institution to brainstorm the barriers that, if removed, could revolutionise cancer research and transform patient outlook.
Submit your idea by 15 November 2019. |
|
|---|
|
|---|
|
|
 FUNDING OPPORTUNTIY IN PREVENTION RESEARCH The UK Prevention Research Partnership (UKPRP) has launched its 2nd funding call for proposals for new Consortium and Network awards. The UKPRP supports research into the primary prevention of non-communicable diseases, including cancer, and awarded 25m to 8 projects in its first funding round. Proposals should focus on solutions, policies and strategies which are sustainable, replicable, feasible and affordable and which aim to enable change within complex adaptive systems. Deadline: 14 November |
|
|---|
|  DEADLINE APPROACHING: PURSUE CANCER RESEARCH IN THE US Applications for the Fulbright-CRUK Scholar Awards will be closing in just over a month. Open to academic and clinician researchers at postdoc level or above, the scheme allows you to undertake a 3-12 month research visit to the US. Its an amazing scheme. It supports you in preparation for travel, offers unique opportunities and events while in the US and the Fulbright network connects you with fellow scholars from all disciplines from across the world, says Dr Stuart Williamson, a recent Fulbright Scholar. Deadline: 6 November 2019 |
|
|---|
|
|---|
|
|
| | | MANCHESTER, UK 07 October 2019 |
|
|---|
|
|---|
| | | KING'S COLLEGE LONDON, LONDON, UK 08 October 2019 |
|
|---|
|
|---|
| | | LONDON, UK 15 October 2019 |
|
|---|
|
|---|
| | | LONDON, UK 07 November 2019 |
|
|---|
|
|---|
| | | LONDON, UK 25 November 2019 |
|
|---|
|
|---|
|
|
| Been forwarded this email? Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
